Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

GUIDE.MRD: A consortium guiding multimodal therapies against minimal residual disease by liquid biopsy and ctDNA implementation in clinical practice

Trial in progress

ESMO Congress 2023